Centessa Pharmaceuticals
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Ashley Rd Fl 3, Altrincham, Cheshire, ...Phone Number
(267) 609-7550Website
www.centessa.comRevenue
-Stock Symbol
CNTAIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Centessa Pharmaceuticals
Headquartered in Cambridgeshire, United Kingdom, Centessa Pharmaceuticals Limited is a biopharmaceutical. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Centessa Pharmaceuticals was established in 2021.Explore more
Centessa Pharmaceuticals Org Chart
SS
Vendor Management Senior Director, Strategic ...
JK
Director, SEC Reporting & Technical Accountin...
AB
Associate Director, Financial Systems
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Centessa Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Centessa Pharmaceuticals launches new products
Check out if Centessa Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Centessa Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Centessa Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Centessa Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Centessa Pharmaceuticals has new funding data
Centessa Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Centessa Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Centessa Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Centessa Pharmaceuticals
Compare insights from companies similar to Centessa Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Centessa Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Centessa Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Centessa Pharmaceuticals.
Centessa Pharmaceuticals financials insights
Gather financial insights about Centessa Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Multiple Rounds
$880M
2025
Stock/Share Issuance
$250M
Centessa Pharmaceuticals Tech Stack
A closer look at the technologies used by Centessa Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Centessa Pharmaceuticals News & Media
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Lilly.SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)
NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The...Wilson Sonsini Advises Centessa on IP Matters Related to Acquisition by Lilly
On March 31, 2026, Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, announced a definitive agreement for Eli Lilly and Company (Lilly), an American multinational pharmaceutical company, to acquire Centessa. Under the terms of the transaction agreement, Lilly will acquire all…Centessa (CNTA) Soars to All-Time High on 38% Upside from Eli Lilly Merger
Centessa Pharmaceuticals PLC (NASDAQ:CNTA) is one of the 10 Stocks Dominating Today’s Market Surge. Centessa soared to a new all-time high on Tuesday, as investors gobbled up shares following news that it is set to be acquired by giant weight loss drugmaker Eli Lilly and Company, for $6.3 billion. In a statement, Eli Lilly said […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Centessa Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Headquartered in Cambridgeshire, United Kingdom, Centessa Pharmaceuticals Limited is a biopharmaceutical. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Centessa Pharmaceuticals was established in 2021.... Read More
